Literature DB >> 30022411

The Value of Outpatient Imaging-Based Cancer Screening Episodes.

Joshua M Liao1,2,3, Anirban Basu4, Christoph I Lee5,6.   

Abstract

In order to shift US health care towards greater value, the Centers for Medicare & Medicaid Services (CMS) is exploring outpatient episode-based cost measures under the new Quality Payment Program and planning a bundled payment program that will introduce the first ever outpatient episodes of care. One novel approach to capitalize on this paradigm shift and extend bundled payment policies is to engage primary care physicians and specialists by bundling outpatient imaging studies and associated procedures-central tools in disease screening and diagnosis, but also tools that are expensive and susceptible to increasing health care costs and patient harm. For example, both breast and lung cancer screening represent target areas ripe for bundled payment given high associated costs and variation in management strategies and suboptimal care coordination between responsible clinicians. Benefits to imaging-based screening episodes include stronger alignment between providers (primary care physicians, radiologists, and other clinicians), reduction in unwarranted variation, creation of appropriateness standards, and ability to overcome barriers to cancer screening adherence. Implementation considerations include safeguarding against providers inappropriately withholding care as well as ensuring that accountability and financial risk are distributed appropriately among responsible clinicians.

Entities:  

Keywords:  bundled payment; cancer screening; episodes of care; health care value; health policy

Mesh:

Year:  2018        PMID: 30022411      PMCID: PMC6109007          DOI: 10.1007/s11606-018-4571-y

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  12 in total

Review 1.  Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness.

Authors:  Bernardo H L Goulart; Mark E Bensink; David G Mummy; Scott D Ramsey
Journal:  J Natl Compr Canc Netw       Date:  2012-02       Impact factor: 11.908

2.  Medical-Imaging Stewardship in the Accountable Care Era.

Authors:  Daniel J Durand; Jonathan S Lewin; Scott A Berkowitz
Journal:  N Engl J Med       Date:  2015-10-29       Impact factor: 91.245

3.  The cost of breast cancer screening in the United States: a picture is worth ... a billion dollars?

Authors:  Joann G Elmore; Cary P Gross
Journal:  Ann Intern Med       Date:  2014-02-04       Impact factor: 25.391

4.  Physician practice variation under orthopedic bundled payment.

Authors:  Joshua M Liao; Ezekiel J Emanuel; Gary L Whittington; Dylan S Small; Andrea B Troxel; Jingsan Zhu; Wenjun Zhong; Amol S Navathe
Journal:  Am J Manag Care       Date:  2018-06       Impact factor: 2.229

5.  Aligning incentives for value: The internal performance framework at Partners HealthCare.

Authors:  Brian W Powers; Amol S Navathe; Sreekanth K Chaguturu; Timothy G Ferris; David F Torchiana
Journal:  Healthc (Amst)       Date:  2016-05-18

6.  Baptist Health System: Succeeding in bundled payments through behavioral principles.

Authors:  Joshua M Liao; Amanda Holdofski; Gary L Whittington; Michael Zucker; Sergio Viroslav; David L Fox; Amol S Navathe
Journal:  Healthc (Amst)       Date:  2016-05-19

7.  Breast Cancer Screening in 2018: Time for Shared Decision Making.

Authors:  Nancy L Keating; Lydia E Pace
Journal:  JAMA       Date:  2018-05-01       Impact factor: 56.272

8.  National Performance Benchmarks for Modern Diagnostic Digital Mammography: Update from the Breast Cancer Surveillance Consortium.

Authors:  Brian L Sprague; Robert F Arao; Diana L Miglioretti; Louise M Henderson; Diana S M Buist; Tracy Onega; Garth H Rauscher; Janie M Lee; Anna N A Tosteson; Karla Kerlikowske; Constance D Lehman
Journal:  Radiology       Date:  2017-02-28       Impact factor: 11.105

9.  Variability in radiologists' interpretations of mammograms.

Authors:  J G Elmore; C K Wells; C H Lee; D H Howard; A R Feinstein
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

10.  Reducing false-positive biopsies: a pilot study to reduce benign biopsy rates for BI-RADS 4A/B assessments through testing risk stratification and new thresholds for intervention.

Authors:  Chris I Flowers; Cristina O'Donoghue; Dan Moore; Adeline Goss; Danny Kim; June-Ho Kim; Sjoerd G Elias; Julia Fridland; Laura J Esserman
Journal:  Breast Cancer Res Treat       Date:  2013-06-14       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.